Fulgent Genetics Inc
Research Fulgent Genetics Inc (FLGT) on Bullrun: market cap USD 548.92M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFLGT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 548.92M
- Financial periodQ2 2026
- RevenueUSD 85.39M
- Net income-USD 29.53M
- Free cash flow-USD 27.62M
- Gross margin30.1%
Valuation Snapshot
latest market cap is USD 548.92M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 322.67M | -USD 60.51M | -USD 124.21M | 40.6% | -1.96 | USD 50.19M | USD 7.68M | USD 1.11B |
| FY2024 | USD 283.47M | -USD 42.71M | -USD 19.26M | 37.8% | -1.41 | USD 55.14M | USD 8.47M | USD 1.13B |
| FY2023 | USD 289.21M | -USD 167.83M | USD 4.80M | 36.1% | -5.64 | USD 97.47M | USD 15.25M | USD 1.14B |
| FY2022 | USD 618.97M | USD 143.40M | USD 234.75M | 59.3% | n/a | USD 79.51M | USD 20.79M | USD 1.27B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 548.92M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 816.50M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 569.63M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 856.69M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 900.10M | 3.4 | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.03B | 6.1 | n/a | n/a |
About Fulgent Genetics Inc
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Fulgent Genetics Inc's market cap?
Fulgent Genetics Inc's market capitalization is USD 548.92M.
What does Fulgent Genetics Inc do?
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases.